Impact of Atrial Fibrillation Pattern on Edoxaban Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease: A Secondary Analysis of the EPIC-CAD Randomized Clinic
5 hours ago
- #antithrombotic therapy
- #coronary artery disease
- #atrial fibrillation
- The study compared edoxaban monotherapy with dual antithrombotic therapy in patients with atrial fibrillation (AF) and stable coronary artery disease.
- No significant difference in the primary outcome (net adverse clinical events) was found between paroxysmal and nonparoxysmal AF patients.
- Edoxaban monotherapy significantly reduced the risk of adverse events compared to dual therapy in both AF patterns.
- The findings suggest that AF pattern does not influence the effectiveness of edoxaban monotherapy in this patient group.